Biosynthesis of monodispersed silver nanoparticles and their activity against Mycobacterium tuberculosis Online publication date: Sat, 12-Jul-2014
by Afreen Banu; Vandana Rathod
International Journal of Biomedical Nanoscience and Nanotechnology (IJBNN), Vol. 3, No. 1/2, 2013
Abstract: In this study, we report the characterisation of biosynthesised silver nanoparticles and investigate the antibacterial effects of biologically synthesised silver nanoparticles (AgNPs) on Mycobacterium tuberculosis. There is an urgent need to develop new anti-tuberculosis drugs, highlighted by the ongoing rise in tuberculosis (TB) cases worldwide. One worrying factor in the current TB problem is the prevalence of multi-drug resistant (MDR) strains. Increased resistance of Mycobacterium tuberculosis (M. tuberculosis) to antibiotics has led the researchers to develop a good antibacterial agent to overcome this problem. A colorimetric, microplate-based Alamar Blue assay (MABA) method was used to determine the MICs of isoniazid (INH), rifampin, streptomycin (SM), and ethambutol (EMB) for M. tuberculosis clinical isolates and silver nanoparticles against multi-drug resistance strains of M. tuberculosis isolated from MABA method.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Biomedical Nanoscience and Nanotechnology (IJBNN):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook